A study found that using iGlarLixi therapy is safe and effective for treating diabetes, regardless of whether or not patients are also taking SGLT2 inhibitors. This combination therapy does not pose any additional risks and can help improve outcomes for patients with diabetes. The study emphasizes the importance of using a personalized approach to diabetes…
Providence’s Digital Innovation Group has spun out a new tech startup called Praia Health, focused on personalizing healthcare journeys for patients. The platform, backed by a $20 million funding round, aims to improve consumer engagement and provide true personalization at scale. Praia’s platform uses identity and profile technology to unify fragmented data sources and offers…
Dr. Ray O’Connor compiles and writes about the latest clinical studies, focusing on their practical implications. Studies discussed include the effectiveness of dancing for weight loss, the health benefits of transitioning to clean energy sources, the impact of pet ownership on cognitive decline, and the association between protein intake and healthy aging. Additionally, studies on…
The obesity epidemic is a global issue with significant health implications. Innovative solutions like the vibrating ingestible device offer hope for non-invasive weight management by targeting stomach receptors to induce feelings of fullness. Although further research and human trials are needed, early results from animal studies are promising. The current COVID-19 pandemic has exacerbated obesity…
Digital health startup Eko Health has received FDA clearance for its AI-enabled Eko Low Ejection Fraction Tool (ELEFT) that helps detect low ejection fraction, a sign of heart failure, in just 15 seconds during routine exams with an Eko stethoscope. This tool is added to Eko’s SENSORA Cardiac Early Detection Platform, which already has FDA-cleared…
State and local governments are receiving billions of dollars in settlements from companies involved in the opioid crisis. KFF Health News has been tracking how this money is being used. BrownGreer, the administering firm, recently made settlement data public on a website, allowing users to see how much money their area has received or will…
A Cincinnati-based life sciences company, Asha Therapeutics, announced the advancement of its development candidate, ASHA-624, as a potential disease modifying therapy for amyotrophic lateral sclerosis (ALS). ASHA-624 is an intra-molecular compound that targets the SARM1 protein, which promotes axonal degeneration and neurodegeneration in ALS. Preclinical models have shown that ASHA-624 can reverse motor impairment and…
Roivant Sciences is facing questions about whether its business model can survive its recent successes. The company’s drug brepocitinib showed positive results in a study for non-infectious uveitis, while also announcing a $1.5 billion stock buyback, including shares owned by Sumitomo. Many of Roivant’s drugs, including brepocitinib, were initially part of larger pharmaceutical companies like…
The Royal College of General Practitioners and the Faculty of Public Health have topped the climate and health scorecard, evaluating UK health organisations’ efforts to tackle the climate emergency. 19 organizations, including nine medical royal colleges, participated in the initiative, which assesses internal operations, finance, education, and advocacy. Experts from various fields contributed to the…
A team of scientists from the German Cancer Research Center has developed a new method called “Small-Scale Magneto-Oscillatory Localization” (SMOL) to track and control miniature robots and surgical instruments inside the body in real-time. The method is based on a magnetic oscillator that can be excited to vibrate mechanically and then detected using magnetic sensors….
